Skip to main content
Erschienen in: Medical Oncology 6/2014

01.06.2014 | Original Paper

Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer

verfasst von: William Whitney Robertson, Matthew A. Steliga, Eric R. Siegel, Konstantinos Arnaoutakis

Erschienen in: Medical Oncology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Management of advanced non-small cell lung cancer patients is dependent on the histologic diagnosis for both testing and treatment. This study was designed to determine the ability of fine needle aspiration and core biopsies to correctly determine histologic diagnosis in non-small cell lung cancer. Our institutional cardiothoracic surgery database was reviewed for cases of non-small cell lung cancer treated with lobectomy after a preoperative biopsy by CT guidance or bronchoscopy over a 10-year period from 2002 to 2011. The histologic diagnosis of the final lobectomy specimen was compared to the histologic diagnosis from the preoperative biopsy, and the concordance rate was calculated. 119 biopsy specimens from 117 patients were reviewed. Eighty of the 119 biopsies had the same histologic diagnosis as the lobectomy specimen, yielding an overall concordance rate of 67.2 %. Patients with poorly differentiated tumors were at the highest risk of an incorrect histologic diagnosis on preoperative biopsy. Reliance on fine needle aspiration and core biopsies to determine histologic diagnosis in non-small cell lung cancer may put some patients at risk for suboptimal treatment.
Literatur
1.
Zurück zum Zitat American Cancer Society. Cancer Facts and Figures 2011. Atlanta: American Cancer Society; 2011. American Cancer Society. Cancer Facts and Figures 2011. Atlanta: American Cancer Society; 2011.
2.
Zurück zum Zitat Johnson D, et al. Randomized phase ii trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously treated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22:2184–91.PubMedCrossRef Johnson D, et al. Randomized phase ii trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously treated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22:2184–91.PubMedCrossRef
3.
Zurück zum Zitat Scagliotti G, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy naïve patients with advanced stage non-small cell lung cancer. J Clin Oncol. 2008;26(21):3543–51.PubMedCrossRef Scagliotti G, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy naïve patients with advanced stage non-small cell lung cancer. J Clin Oncol. 2008;26(21):3543–51.PubMedCrossRef
5.
Zurück zum Zitat Yilmaz A, et al. Cell type accuracy of transthoracic fine needle aspiration material in primary lung cancer. Respirology. 2001;6:91–4.PubMedCrossRef Yilmaz A, et al. Cell type accuracy of transthoracic fine needle aspiration material in primary lung cancer. Respirology. 2001;6:91–4.PubMedCrossRef
6.
Zurück zum Zitat Fassina A, et al. Role and accuracy of rapid on-site evaluation of CT guided fine needle aspiration cytology of lung nodules. Cytopathology. 2011;22:306–12.PubMedCrossRef Fassina A, et al. Role and accuracy of rapid on-site evaluation of CT guided fine needle aspiration cytology of lung nodules. Cytopathology. 2011;22:306–12.PubMedCrossRef
7.
Zurück zum Zitat Lindeman N, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. J Thorac Oncol. 2013;8:823–59.PubMedCrossRef Lindeman N, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors. J Thorac Oncol. 2013;8:823–59.PubMedCrossRef
8.
Zurück zum Zitat Travis W, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011;6:244–85.PubMedCrossRef Travis W, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011;6:244–85.PubMedCrossRef
Metadaten
Titel
Accuracy of fine needle aspiration and core lung biopsies to predict histology in patients with non-small cell lung cancer
verfasst von
William Whitney Robertson
Matthew A. Steliga
Eric R. Siegel
Konstantinos Arnaoutakis
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 6/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0967-7

Weitere Artikel der Ausgabe 6/2014

Medical Oncology 6/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.